Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 37.25 USD -1.4% Market Closed
Market Cap: 5.9B USD
Have any thoughts about
Ionis Pharmaceuticals Inc?
Write Note

Ionis Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ionis Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Gross Profit
$792.6m
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$37.3B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$22B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$12B
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
17%

See Also

What is Ionis Pharmaceuticals Inc's Gross Profit?
Gross Profit
792.6m USD

Based on the financial report for Sep 30, 2024, Ionis Pharmaceuticals Inc's Gross Profit amounts to 792.6m USD.

What is Ionis Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
-1%

Over the last year, the Gross Profit growth was 31%. The average annual Gross Profit growth rates for Ionis Pharmaceuticals Inc have been 7% over the past three years , -1% over the past five years .

Back to Top